Go Pro

Smith & Nephew SNATS (SNN) Stock Forecast & Price Target

Smith & Nephew SNATS logo
$28.91 +0.04 (+0.14%)
As of 09/4/2026 03:58 PM Eastern

Smith & Nephew SNATS - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
2
Hold
8
Buy
1

Based on 11 Wall Street analysts who have issued ratings for Smith & Nephew SNATS in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 11 analysts, 2 have given a sell rating, 8 have given a hold rating, and 1 has given a buy rating for SNN.

Consensus Price Target

$30.93
6.97% Upside
According to the 11 analysts' twelve-month price targets for Smith & Nephew SNATS, the average price target is $30.93. The highest price target for SNN is $31.85, while the lowest price target for SNN is $30.00. The average price target represents a forecasted upside of 6.97% from the current price of $28.91.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for SNN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Smith & Nephew SNATS and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SNN Analyst Ratings Over Time

TypeCurrent Forecast
9/7/25 to 9/7/26
1 Month Ago
8/8/25 to 8/8/26
3 Months Ago
6/9/25 to 6/9/26
1 Year Ago
9/7/24 to 9/7/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
2 Buy rating(s)
1 Buy rating(s)
0 Buy rating(s)
Hold
8 Hold rating(s)
6 Hold rating(s)
5 Hold rating(s)
4 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$30.93$30.93$30.93$36.00
Forecasted Upside6.97% Upside2.73% Upside-1.33% Downside-5.48% Downside
Consensus RatingReduceHoldHoldHold

SNN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SNN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Smith & Nephew SNATS Stock vs. The Competition

TypeSmith & Nephew SNATSHealthcare CompaniesBroader Market
Consensus Rating Score
1.91
2.30
2.53
Consensus RatingReduceHoldModerate Buy
Predicted Upside6.97% Upside928.71% Upside14.03% Upside
News Sentiment Rating
Neutral News

See Recent SNN News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
9/4/2026
Weiss Ratings logo
Weiss Ratings
5 of 5 stars
 UpgradeHold (C)Hold (C+)
9/2/2026
Morgan Stanley logo
Morgan Stanley
3 of 5 stars
 DowngradeOverweightEqual Weight
8/31/2026
BTIG Research logo
BTIG Research
3 of 5 stars
Ryan Zimmerman
Ryan Zimmerman
3 of 5 stars
Initiated CoverageNeutral
8/7/2026 DowngradeHoldStrong Sell
8/6/2026Reiterated RatingOverweightNeutral
8/5/2026DowngradeEqual WeightUnderweight
6/4/2026 DowngradeBuyHold
5/25/2026 Reiterated RatingBuy
5/11/2026 Set Target$31.85+8.08%
5/11/2026Lower TargetHold$32.00 ➝ $30.00+1.81%
12/15/2025 DowngradeOutperformSector Perform
3/12/2025DowngradeBuyNeutral
11/6/2024DowngradeBuyHold
11/1/2024 DowngradeBuyHold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 06:48 AM ET.


SNN Forecast - Frequently Asked Questions

According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Smith & Nephew SNATS is $30.93, with a high forecast of $31.85 and a low forecast of $30.00.

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew SNATS in the last twelve months. There are currently 2 sell ratings, 8 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "reduce" SNN shares.

According to analysts, Smith & Nephew SNATS's stock has a predicted upside of 6.97% based on their 12-month stock forecasts.

Over the previous 90 days, Smith & Nephew SNATS's stock had 4 downgrades and 1 upgrade by analysts.

Smith & Nephew SNATS has been rated by research analysts at Barclays, BTIG Research, JPMorgan Chase & Co., Morgan Stanley, Weiss Ratings, and Zacks Research in the past 90 days.

Analysts like Smith & Nephew SNATS less than other "healthcare" companies. The consensus rating for Smith & Nephew SNATS is Reduce while the average consensus rating for "healthcare" companies is Hold. Learn more on how SNN compares to other companies.


MarketBeat monitors more than a dozen sources for Smith & Nephew SNATS analyst ratings, with the most recent rating issued on 9/4/2026.
From Our Partners